AT&T's stock has been active in disease times, with key developments including a $5.75B deal with Lumen to boost its fiber network. The stakes are high between AT&T and
Verizon amidst market volatility as well as in the Artificial intelligence realm against the likes of
Palantir. Various noticeable transactions were recorded including purchases and sales by several entities. For instance, investments made by US Financial Advisors LLC, Vivaldi Capital Management LP, and Novem Group among others, while Public Employees Retirement System of Ohio and Man Group plc opted to sell. AT&T's
dividend declaration for common and preferred shares may be a gesture of financial health. However, its stock fell 1.1% after the last earnings report causing Evercore ISI to maintain the stock in line with $27 target. Opinions on whether the stock is a buy, sell or fair value still fluctuate. AT&T's $5.75B acquisition of Lumen's business projects expansion to 60 million locations by 2030. The company also faced a minor setback where it urged shareholders to reject the $26.38 mini-tender offer and SEC red flags.
Att Stocks News Analytics from Thu, 12 Dec 2024 22:30:28 GMT to Sat, 24 May 2025 20:00:00 GMT -
Innovation 4
- Information 5
- Rumor 0
